Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with β- cyclodextrin

Current Drug Delivery

Volumn 5, Issue 1, 2008, Pages 1-6

  Bhargava, S ^a,b   Agrawal, G P ^b  

^a AICTE   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

cyclodextrin; Cefpodoxime proxetil; Inclusion complex; Solubilization

Indexed keywords

BETA CYCLODEXTRIN; CEFPODOXIME PROXETIL; PENICILLIN G;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANTI-BACTERIAL AGENTS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CEFTIZOXIME; CHEMISTRY, PHYSICAL; COLONY COUNT, MICROBIAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FREEZE DRYING; MICROSCOPY, ELECTRON, SCANNING; NEISSERIA GONORRHOEAE; PENICILLIN RESISTANCE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 38949136984     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720108783330998     Document Type: Article

References (21)

1. Challa, R.; Ahuja, A.; Ali, J.; Khar, R.K. AAPS Pharm. Sci. Tech., 2005, 6(2), E319.
2. Hedges, R.A. Chem. Rev., 1998, 98, 2035.
3. Loftsson, T.; Bewster, M.E. J. Pharm. Sci., 1996, 85(10), 1017.
4. Borin, M.T.; Khwashioki, L.; Idris, B.; Mulaya, K. Antimicrob. Agent Chemother., 1990, 34, 1094.
5. Neu, H.C.; Nai-Xun, C.; Labthavikul, P. Antimicrob. Agent Chemother., 1984, 26(2), 174.
6. Higuchi, T.; Connors, K.A. Adv. Anal. Chem. Instrum., 1965, 4, 117.
7. Timmy, S.E.; Victor, S.P.; Sharma, C.P.; Kumari, V.J. Trend Biomat. Artif. Organ, 2002, 15(2), 48.
8. Liu, F.; Kildsig, D.O.; Mitra, A.K. Pharm. Res., 1992, 9, 1671.
9. Rao, Y.S.; Chowdhary, K.P.R.; SheshagiriRao, J.V.L.N. Ind. J. Pharm. Sci., 2003, 31(5), 307.
10. Loftsson, T.; Olafsdottir, B.J.; Fridriksdottir, H.; Jandottir, S. Eur. J. Pharm. Sci., 1993, 85, 1017.
11. Fromming, K.H.; Szejtli, J. Cyclodextrins in pharmacy, Kluwer Publishing Dordrecht London, 1994.
12. Diaz, D.; Llanos, E.C.M.; Bernad, M.J.B. Drug Dev. Ind. Pharm., 1994, 25, 107.
13. Marques, C.H.; Hadgraft, J.; Kellaway, I. Int. J. Pharm., 1994, 63, 259.
14. British Pharmacopoeia, British Pharmacopoeial Commission, London SW85NQ, 1999.
15. Khan, K.A. J. Pharm. Pharmacol., 1975, 27, 48.
16. Washington, J.A.II; Susceptibility tests: agar dilution. In Lennette EH, Balows A, Hausler WJ Jr., Shadomy HJ (eds.), Manual of clinical microbiology, 1985, 4th ed., pp. 967-971.
17. Schaadt, R.A.; Yagi, B.H.; Zurenkp, G.E. Antimicrob. Agents Chemother., 1990, 34(2),371.
18. Martin Del Valle, E.M. Process Biochem., 2004, 39, 1033.
19. Connors, K.A. Chem. Rev., 1997, 97, 1325.
20. Reddy, N.M.; Rehana, T.; Ramkrishna, S.; Chowdhary, K.P.R.; Diwan, P.V. AAPS Pharm. Sci., 2004, 6(1), E1.
21. Barillaro, V.; Evrard, B.; Delattre, L.; Piel, G. AAPS Pharm. Sci., 2005, 7(1), E149.